Thailand: FDA defends weed ad rules
The Food and Drug Administration (FDA) defended its draft regulations on the licencing and advertising of marijuana-based medications, saying that the regulations “were not designed to benefit large, foreign pharmaceutical companies”. The FDA issued the statement in response to a remark made by former senator, Rosana Tositrakul, through which she asked whether the ministerial regulations […]
Read More